A question of balance--positive versus negative allosteric modulation of GABA(A) receptor subtypes as a driver of analgesic efficacy in rat models of inflammatory and neuropathic pain
- PMID: 21439986
- DOI: 10.1016/j.neuropharm.2011.03.017
A question of balance--positive versus negative allosteric modulation of GABA(A) receptor subtypes as a driver of analgesic efficacy in rat models of inflammatory and neuropathic pain
Abstract
After injury GABA(A) receptor positive allosteric modulators (PAMs) mediate robust analgesia in animals via putative restoration of post-synaptic GABA(A)-α2 and -α3 receptor function within the spinal cord. GABA can also act at GABA(A) receptors localized on primary afferent neurones to inhibit presynaptic neurotransmitter release and produce analgesia via a process called primary afferent depolarization (PAD). Some forms of injury might sufficiently enhance PAD to shift it into a net excitatory process. Thus, negative allosteric modulators (NAMs) might also possess analgesic activity. We have compared compounds capable of either positively or negatively modulating GABA(A) receptors in rat models associated with injury-induced central sensitization. The subtype-selective PAMs NS11394 (1-10 mg/kg) and TPA023 (3-30 mg/kg) attenuated formalin-induced nocifensive behaviours. Similarly, both compounds reversed hindpaw mechanical hypersensitivity and weight bearing deficits in carrageenan-inflamed and nerve-injured rats. The non-selective PAM diazepam (1-5 mg/kg) was ineffective in all models. Surprisingly, both the non-selective NAM FG-7142 (3-30 mg/kg) and the α5-selective NAM α5IA-II (10-60 mg/kg) also attenuated formalin-induced nocifensive behaviours. In carrageenan-inflamed rats α5IA-II reversed mechanical hypersensitivity and weight bearing deficits whilst FG-7142 only attenuated weight bearing deficits. This picture was essentially reversed in nerve-injured rats for these two NAMs. With the exception of NS11394, all compounds attenuated exploratory motility behaviour in rats, either as a consequence of sedative or anxiogenic-like side-effects. These data indicate that the preferred selectivity and activity profiles for mediating analgesia upon activation of GABA(A) receptors might be more complex than previously anticipated, and is worthy of further exploration.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Positive allosteric modulation of GABA-A receptors reduces capsaicin-induced primary and secondary hypersensitivity in rats.Neuropharmacology. 2012 Dec;63(8):1360-7. doi: 10.1016/j.neuropharm.2012.08.002. Epub 2012 Aug 17. Neuropharmacology. 2012. PMID: 22985969
-
GABAA α5 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085.Biochem Pharmacol. 2015 Feb 1;93(3):370-9. doi: 10.1016/j.bcp.2014.12.010. Epub 2014 Dec 25. Biochem Pharmacol. 2015. PMID: 25542996
-
Developing analgesics by enhancing spinal inhibition after injury: GABAA receptor subtypes as novel targets.Trends Pharmacol Sci. 2009 Sep;30(9):453-9. doi: 10.1016/j.tips.2009.06.004. Epub 2009 Sep 2. Trends Pharmacol Sci. 2009. PMID: 19729210 Review.
-
Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain.J Pharmacol Exp Ther. 2008 Dec;327(3):969-81. doi: 10.1124/jpet.108.144568. Epub 2008 Sep 12. J Pharmacol Exp Ther. 2008. PMID: 18791060
-
The role of GABA(A) receptor subtypes as analgesic targets.Drug News Perspect. 2010 Jul-Aug;23(6):351-60. doi: 10.1358/dnp.2010.23.6.1489909. Drug News Perspect. 2010. PMID: 20697602 Review.
Cited by
-
Transmission pathways and mediators as the basis for clinical pharmacology of pain.Expert Rev Clin Pharmacol. 2016 Oct;9(10):1363-1387. doi: 10.1080/17512433.2016.1204231. Epub 2016 Jul 4. Expert Rev Clin Pharmacol. 2016. PMID: 27322358 Free PMC article.
-
Therapeutic Basis of Clinical Pain Modulation.Clin Transl Sci. 2015 Dec;8(6):848-56. doi: 10.1111/cts.12282. Epub 2015 May 11. Clin Transl Sci. 2015. PMID: 25962969 Free PMC article. Review.
-
Expression and effect of sodium-potassium-chloride cotransporter on dorsal root ganglion neurons in a rat model of chronic constriction injury.Neural Regen Res. 2020 May;15(5):912-921. doi: 10.4103/1673-5374.268904. Neural Regen Res. 2020. PMID: 31719257 Free PMC article.
-
Sex-related exacerbation of injury-induced mechanical hypersensitivity in GAD67 haplodeficient mice.Pain. 2024 Jan 1;165(1):192-201. doi: 10.1097/j.pain.0000000000003012. Epub 2023 Aug 11. Pain. 2024. PMID: 37578506 Free PMC article.
-
Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes.Nat Rev Drug Discov. 2011 Jul 29;10(9):685-97. doi: 10.1038/nrd3502. Nat Rev Drug Discov. 2011. PMID: 21799515 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous